Pharma News

Some survivors of ebolavirus outbreaks make antibodies that can broadly neutralize these viruses--and now, scientists at Scripps Research have illuminated how these antibodies can disable the viruses so effectively. The insights may be helpful for developing effective therapies.

Stanford scientists saved drops of the COVID-19 vaccine destined for the garbage can, reverse engineered them, and have posted the mRNA sequence that powers the vaccine on GitHub for all to see.

Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC, moves into clinical trials. The Department of Biotechnology (DBT), Ministry of Science & Technologyhas announced that it has approved additional funding towards clinical studies of India's'first of its kind' mRNA-based COVID-19 vaccine - HGCO19, developed by Pune-based biotechnology company Gennova Biopharmaceuticals Ltd.

Pharmacist India is following a comprehensive approach to tackle COVID-19 pandemic in a proactive and pre-emptive manner. In this context, as early as May 2020, India constituted a Task Force headed by Principal Scientific Advisor to encourage R&D for vaccine manufacture & constituted in August 2020 an Expert Group headed by Member, NITI to assist in roll out of the Covid vaccination programme. It was because of these strategies that India became the first country to have two “Made in India” Covid vaccines for domestic vaccination drive.

Dr. Reddys Laboratories Ltd announced that it has received the permission from the Drug Controller General of India(DCGI)to import the Sputnik vaccine into India for restricted use in emergency situations as per the provisions of the New Drug and Clincial Trials rules, 2019 under the Drugs and Cosmetics Act.

India bans exports of injection Remdesivir and Remdesivir API and all domestic manufactures of Remdesivir to display on their website, details of their stockists/ distributors to facilitate access to the drug.

India is witnessing a recent surge in COVID cases. As on 11.04.2021, there are 11.08 lakh active COVID cases and they are steadily increasing. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients. There is a potential of further increase in this demand in the coming days.